These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Immediate adverse reactions to intravenous iodinated contrast media in computed tomography. Juchem BC; Dall'Agnol CM Rev Lat Am Enfermagem; 2007; 15(1):78-83. PubMed ID: 17375236 [TBL] [Abstract][Full Text] [Related]
30. Gadolinium and nephrogenic systemic fibrosis: have we overreacted? Penfield JG; Reilly RF Semin Dial; 2011; 24(5):480-6. PubMed ID: 21913988 [TBL] [Abstract][Full Text] [Related]
31. Contrast media and cutaneous reactions. Part 1. Immediate hypersensitivity reactions to contrast media and gadolinium deposition. Tasker F; Fleming H; McNeill G; Creamer D; Walsh S Clin Exp Dermatol; 2019 Dec; 44(8):839-843. PubMed ID: 31112335 [TBL] [Abstract][Full Text] [Related]
34. Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Namasivayam S; Kalra MK; Torres WE; Small WC Emerg Radiol; 2006 Jul; 12(5):210-5. PubMed ID: 16688432 [TBL] [Abstract][Full Text] [Related]
35. A timely reminder about an evolving clinical entity: nephrogenic systemic fibrosis and gadolinium use in CKD. Jamboti J Nephrology (Carlton); 2007 Jun; 12(3):316. PubMed ID: 17498132 [No Abstract] [Full Text] [Related]
36. [Suggestions for prevention of adverse reactions after intravasal administration of iodinated contrast media]. Kuefner MA; Heinrich M; Bautz W; Uder M Rontgenpraxis; 2008; 56(6):199-206. PubMed ID: 19294866 [TBL] [Abstract][Full Text] [Related]
37. MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction. Thomsen HS; Marckmann P Eur J Radiol; 2008 May; 66(2):153-9. PubMed ID: 18343071 [TBL] [Abstract][Full Text] [Related]
38. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents. Kitajima K; Maeda T; Watanabe S; Ueno Y; Sugimura K Int J Urol; 2012 Sep; 19(9):806-11. PubMed ID: 22571387 [TBL] [Abstract][Full Text] [Related]
40. Pharmacovigilance: what to do if you see an adverse reaction and the consequences. Stenver DI Eur J Radiol; 2008 May; 66(2):184-6. PubMed ID: 18372136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]